Clinical Trials Logo

Gastric Cancer Stage clinical trials

View clinical trials related to Gastric Cancer Stage.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06281379 Completed - Gastric Cancer Clinical Trials

Complete Mesogastric Excision With D2 Lympadenectomy for Gastric Cancer:

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

Objective: To define complete mesogastric excision and compare our short term results for the first time in a different population. Study design:Randomised-controlled study Place and duration of the study: Gastroenterological Surgery Clinic,Health Sciences University,Basaksehir City Hospital,Istanbul,Turkey,from April to December 2023. Methodology: We compared short term results of open total gastrectomy+ mesogastrectomy with standard total gastrectomy + D2 lymph node dissection at a tertiary center in terms of peroperative results, histopathological findings and postoperative short- term outcomes with review of the literature. Conclusion: Our aim is to show that mesogastric excision is safe and has advantages over conventional D2 gastrectomy in means of not only peroperative and short-term outcomes, but also disease free survival.Our work is the first study from a different population of the world and our initial results can contribute to the literature for universalization.